Hexadecylphosphocholine: a new and selective antitumor drug
1Max-Planck-Institute for Biophysical Chemistry, University Hospital Göttingen, Germany.
Cancer Treatment Reviews
|September 1, 1990
Summary
Alkylphosphocholines, a novel breast cancer treatment, target cell membranes, not the nucleus. Hexadecylphosphocholine shows high efficacy and selectivity with minimal toxicity in preclinical and early clinical studies.
Area of Science:
- Oncology
- Medicinal Chemistry
- Pharmacology
Background:
- Interdisciplinary research led to alkylphosphocholines, a new class of breast cancer therapeutics.
- Unlike traditional agents, alkylphosphocholines target the cell membrane instead of the cell nucleus.
Purpose of the Study:
- To establish a correlation between chemical structure, antitumor efficacy, and selectivity of alkylphosphocholines.
- To identify optimal molecular structures for enhanced effectiveness and reduced toxicity.
Main Methods:
- Systematic study of alkylphosphocholine metabolism and structure-activity relationships.
- Evaluation of hexadecylphosphocholine in chemically induced rat mammary carcinomas.
- Comparison of oral and intravenous administration routes.
Main Results:
- Established minimal structural requirements for antineoplastic efficacy based on (ether)-lysolecithin metabolism.
- Hexadecylphosphocholine demonstrated highly selective action against rat mammary carcinomas.
- Effective drug concentrations showed no immunosuppression or hematotoxicity, even with complete tumor remission.
Conclusions:
- Alkylphosphocholines represent a promising new class of anticancer agents.
- Hexadecylphosphocholine is a leading candidate due to its selective action and favorable safety profile.
- Preclinical findings are supported by preliminary clinical investigations, suggesting therapeutic potential.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Synthesis of Phosphatidylcholine in the ER Membrane
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.